ETST
Price
$0.20
Change
-$0.00 (-0.00%)
Updated
Aug 29 closing price
Capitalization
58.76M
HKMPY
Price
$49.65
Change
+$1.38 (+2.86%)
Updated
Aug 27 closing price
Capitalization
5.43B
Interact to see
Advertisement

ETST vs HKMPY

Header iconETST vs HKMPY Comparison
Open Charts ETST vs HKMPYBanner chart's image
Earth Science Tech
Price$0.20
Change-$0.00 (-0.00%)
Volume$140.6K
Capitalization58.76M
Hikma Pharmaceuticals
Price$49.65
Change+$1.38 (+2.86%)
Volume$319
Capitalization5.43B
ETST vs HKMPY Comparison Chart in %
Loading...
ETST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HKMPY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ETST vs. HKMPY commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETST is a Hold and HKMPY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 30, 2025
Stock price -- (ETST: $0.20 vs. HKMPY: $49.65)
Brand notoriety: ETST and HKMPY are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ETST: 18% vs. HKMPY: 76%
Market capitalization -- ETST: $58.76M vs. HKMPY: $5.43B
ETST [@Pharmaceuticals: Generic] is valued at $58.76M. HKMPY’s [@Pharmaceuticals: Generic] market capitalization is $5.43B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.6B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ETST’s FA Score shows that 0 FA rating(s) are green whileHKMPY’s FA Score has 1 green FA rating(s).

  • ETST’s FA Score: 0 green, 5 red.
  • HKMPY’s FA Score: 1 green, 4 red.
According to our system of comparison, ETST is a better buy in the long-term than HKMPY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ETST’s TA Score shows that 3 TA indicator(s) are bullish while HKMPY’s TA Score has 5 bullish TA indicator(s).

  • ETST’s TA Score: 3 bullish, 2 bearish.
  • HKMPY’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, HKMPY is a better buy in the short-term than ETST.

Price Growth

ETST (@Pharmaceuticals: Generic) experienced а +3.90% price change this week, while HKMPY (@Pharmaceuticals: Generic) price change was +2.85% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.25%. For the same industry, the average monthly price growth was +68.20%, and the average quarterly price growth was +81.63%.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HKMPY($5.43B) has a higher market cap than ETST($58.8M). ETST has higher P/E ratio than HKMPY: ETST (22.22) vs HKMPY (14.86). ETST YTD gains are higher at: 60.000 vs. HKMPY (2.597). HKMPY has higher annual earnings (EBITDA): 734M vs. ETST (2.93M). HKMPY has more cash in the bank: 127M vs. ETST (1.77M). ETST has less debt than HKMPY: ETST (286K) vs HKMPY (1.31B). HKMPY has higher revenues than ETST: HKMPY (3.22B) vs ETST (33.3M).
ETSTHKMPYETST / HKMPY
Capitalization58.8M5.43B1%
EBITDA2.93M734M0%
Gain YTD60.0002.5972,310%
P/E Ratio22.2214.86150%
Revenue33.3M3.22B1%
Total Cash1.77M127M1%
Total Debt286K1.31B0%
FUNDAMENTALS RATINGS
ETST vs HKMPY: Fundamental Ratings
ETST
HKMPY
OUTLOOK RATING
1..100
2528
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
10
Undervalued
PROFIT vs RISK RATING
1..100
5499
SMR RATING
1..100
1678
PRICE GROWTH RATING
1..100
4278
P/E GROWTH RATING
1..100
8895
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HKMPY's Valuation (10) in the null industry is somewhat better than the same rating for ETST (74). This means that HKMPY’s stock grew somewhat faster than ETST’s over the last 12 months.

ETST's Profit vs Risk Rating (54) in the null industry is somewhat better than the same rating for HKMPY (99). This means that ETST’s stock grew somewhat faster than HKMPY’s over the last 12 months.

ETST's SMR Rating (16) in the null industry is somewhat better than the same rating for HKMPY (78). This means that ETST’s stock grew somewhat faster than HKMPY’s over the last 12 months.

ETST's Price Growth Rating (42) in the null industry is somewhat better than the same rating for HKMPY (78). This means that ETST’s stock grew somewhat faster than HKMPY’s over the last 12 months.

ETST's P/E Growth Rating (88) in the null industry is in the same range as HKMPY (95). This means that ETST’s stock grew similarly to HKMPY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ETSTHKMPY
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
59%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
61%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
54%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
67%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
47%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
59%
Advances
ODDS (%)
Bullish Trend 22 days ago
84%
Bullish Trend 11 days ago
55%
Declines
ODDS (%)
Bearish Trend 18 days ago
90%
N/A
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
31%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
ETST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HKMPY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PMFMX23.86N/A
N/A
Principal MidCap S&P 400 Index R3
JFNIX69.45N/A
N/A
Janus Henderson Global Life Sciences I
BRWRX26.44N/A
N/A
MFS Blended Research Growth Eq R1
RTIYX12.28N/A
N/A
Russell Inv Multifactor Intl Eq Y
VIVAX71.45N/A
N/A
Vanguard Value Index Inv

ETST and

Correlation & Price change

A.I.dvisor tells us that ETST and RSCI have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ETST and RSCI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETST
1D Price
Change %
ETST100%
N/A
RSCI - ETST
22%
Poorly correlated
N/A
CXXIF - ETST
22%
Poorly correlated
-3.82%
ESALF - ETST
14%
Poorly correlated
-7.32%
HLTRF - ETST
12%
Poorly correlated
N/A
HKMPY - ETST
10%
Poorly correlated
N/A
More

HKMPY and

Correlation & Price change

A.I.dvisor tells us that HKMPY and HROW have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HKMPY and HROW's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HKMPY
1D Price
Change %
HKMPY100%
N/A
HROW - HKMPY
23%
Poorly correlated
+0.03%
CXXIF - HKMPY
22%
Poorly correlated
-3.82%
HYPMY - HKMPY
14%
Poorly correlated
-5.15%
ETST - HKMPY
10%
Poorly correlated
N/A
INDV - HKMPY
8%
Poorly correlated
+1.68%
More